Literature DB >> 10743828

Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.

H Y Kim1, H G Lee, D S Kim.   

Abstract

OBJECTIVE: Kawasaki disease (KD) is an acute systemic vasculitis characterized by marked depletion of peripheral lymphocytes in the acute stage of the disease. We evaluated the degree of apoptosis of peripheral blood mononuclear cells (PBMC) in KD and investigated whether the Fas-Fas ligand system is involved in inducing apoptosis in KD.
METHODS: Fifteen patients with KD were classified into 2 groups, Group KW1 (initial stage of disease, or fever < 5 days) and Group KW2 (fulminant stage of disease, or fever > 5 days). PBMC were isolated and after 5, 24, and 48 h incubation stained and analyzed by flow cytometry. The levels of serum soluble Fas were measured by ELISA. mRNA expression of Fas ligand was evaluated by reverse transcription polymerase chain reaction.
RESULTS: The degree of apoptosis at 24 h was 20.2 +/- 5.6% in Group KW1, higher than that of normal (p < 0.05) and febrile controls (p < 0.01); and 10.8 +/- 2.8% in Group KW2, lower than that of normal (p < 0.01) and febrile controls (p < 0.01). At 48 h the degree of apoptosis was 37.7 +/- 4.2% in Group KW1, significantly higher than normal (p < 0.01) and febrile controls (p < 0.01); and 17.1 +/- 5.6% in Group KW2, lower than normal (p < 0.01) and febrile controls (p < 0.01). The mean level of serum soluble Fas in the acute stage of KD was 0.45 +/- 0.26 ng/ml, significantly lower versus the subacute stage (1.06 +/- 0.40 ng/ml) (p < 0.01). FasL of mRNA was expressed in PBMC of all patients with acute stage KD. whereas no expression was noted in the subacute stage of disease.
CONCLUSION: Marked decrease of peripheral blood lymphocytes in acute stage KD may be caused by the upregulated apoptosis of lymphocytes; Fas-Fas ligand may be involved in this upregulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10743828

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

Authors:  J Kimura; H Takada; A Nomura; T Ohno; Y Mizuno; M Saito; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

2.  Delayed apoptosis of circulating neutrophils in Kawasaki disease.

Authors:  H Tsujimoto; S Takeshita; K Nakatani; Y Kawamura; T Tokutomi; I Sekine
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 3.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

4.  The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies.

Authors:  E Grunebaum; M Blank; S Cohen; A Afek; J Kopolovic; P L Meroni; P Youinou; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

5.  Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease.

Authors:  Jin-Kyong Chun; Dong Won Kang; Byung Won Yoo; Jeon-Soo Shin; Dong Soo Kim
Journal:  Eur J Pediatr       Date:  2009-05-26       Impact factor: 3.183

6.  Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records.

Authors:  Hyojung Paik; Ah-Young Chung; Hae-Chul Park; Rae Woong Park; Kyoungho Suk; Jihyun Kim; Hyosil Kim; KiYoung Lee; Atul J Butte
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

Review 7.  Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.

Authors:  Yu-wen Lv; Jing Wang; Ling Sun; Jian-min Zhang; Lei Cao; Yue-yue Ding; Ye Chen; Ji-juan Dou; Jie Huang; Yi-fei Tang; Wen-tao Wu; Wei-rong Cui; Hai-tao Lv
Journal:  Comput Math Methods Med       Date:  2013-03-06       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.